Moleculin Biotech Announces 1-For-20 Reverse Stock Split, Effective October 20

Moleculin Biotech has announced a 1-for-20 reverse stock split effective October 20, 2026, which will reduce the number of outstanding shares from approximately 20.9 million to about 1.05 million. The reverse stock split will not change the nominal par value of $0.001 per share, and no fractional shares will be issued; instead, stockholders will receive cash for any fractional shares. The company's common stock will continue to trade under the ticker symbol 'MBRX' on The Nasdaq Capital Market following the split.